But HCC cells can inhibit ferroptosis through regulatory mechanisms such as the antioxidant regulator NRF2, the transsulfuration pathway, and mechanistic targets of mTOR, thereby continuing tumor growth [203]. The gene discussed is NFE2L2; the disease is hepatocellular carcinoma.